A shorter, higher-dose radiation treatment for prostate cancer is just as safe and effective as conventional radiotherapy, ...

Sexual function data support enzalutamide use in men with high-risk biochemically recurrent (BCR) prostate cancer.

A study led by UCLA investigators shows that artificial intelligence (AI) could play a key role in improving treatment outcomes for men with prostate cancer by helping physicians determine who is most ...

A new large-scale study co-led by UCLA Health Jonsson Comprehensive Cancer Center investigators provides the strongest ...

A home urine test demonstrated high sensitivity for detection of aggressive prostate cancer, according to study findings.The ...

A study led by UCLA investigators shows that artificial intelligence (AI) could play a key role in improving treatment ...

Cancer impacts millions globally, with lifestyle choices such as smoking, diet, physical activity, alcohol consumption, sun exposure, stress, and slee ...

Prostate cancer remains one of the most commonly diagnosed cancersworldwide, with 1.4 million new cases and over 375,000 ...

Archie Emanuel, Jr., a Vietnam-era veteran, remembered the day he received his diagnosis. “I had all the blood work and the urologist found out I had cancer,” he said. “It hit me so hard. Cancer! Here ...

Adenocarcinoma grows in the tissue of the prostate gland, but other types of cancer can also start in the prostate or spread ...

Lupron is a drug doctors prescribe to treat prostate cancer. It works by reducing testosterone levels in the body, slowing cancer growth. Lupron is the brand name for leuprolide acetate.

You should read both the consultation document and the accompanying evidence (see the committee papers) before making any comments. You must make your comments ...